STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
NeuroVive Pharmaceutical AB (STO:NVP):
First Quarter (1 Jan. 2015 – 31 Mar. 2015)
· Net revenues were SEK 0 (0) and other operating income was SEK 49,000 (43,000).
Help employers find you! Check out all the jobs and post your resume.
NeuroVive Pharmaceutical AB (STO:NVP):
First Quarter (1 Jan. 2015 – 31 Mar. 2015)
· Net revenues were SEK 0 (0) and other operating income was SEK 49,000 (43,000).
Help employers find you! Check out all the jobs and post your resume.
